MARPE re-expansion
relapsed patients
Protocol, case selection, and evidence
Evidence-based approach to second-stage miniscrew-assisted expansion: patient selection, miniscrew anchorage in healed bone, modified activation, and CBCT monitoring.
TL;DR MARPE re-expansion in previously treated patients is clinically feasible when the midpalatal suture demonstrates sufficient healing and bone remodeling has stabilized. A second MARPE application requires reassessment of miniscrew anchorage sites, modified activation protocols to account for scar tissue formation, and careful CBCT monitoring to detect suture reopening and prevent relapse recurrence.
Retreating palatal expansion relapse presents a unique clinical challenge: the midpalatal suture has consolidated after initial MARPE or RPE treatment, bone density has remodeled, and scar tissue formation may complicate a second expansion phase. In this article, Dr. Mark Radzhabov examines the evidence and clinical decision-making for MARPE re-expansion in previously treated patients—including patient selection criteria, miniscrew stability considerations, modified loading protocols, and radiographic indicators of success. This is essential reading for any orthodontist managing recurring transverse deficiency or relapsed skeletal expansion, where retreat outcomes depend heavily on understanding the biology of reopened and scarred palatal sutures.
What is MARPE
re-expansion
and when is it indicated?
MARPE re-expansion represents a distinct clinical entity from primary expansion: it involves placing miniscrews into bone that has already undergone palatal expansion, remodeling, and a period of consolidation. The midpalatal suture, rather than being pristine and responsive to early orthopedic forces, carries a history of disruption and healing. This biological reality shapes every decision—from miniscrew site selection to activation magnitude. In clinical practice, relapse occurs when patients show inadequate initial expansion, insufficient retention, or ongoing skeletal growth that re-establishes a transverse deficiency after successful first-stage treatment. Unlike conventional rapid palatal expansion (RPE), which relies on dental anchorage and tends to produce more dentoalveolar change, MARPE anchors directly to skeletal anatomy via miniscrews, providing more direct suture stress and greater skeletal response. A prospective randomized clinical trial demonstrated that MARPE achieves greater nasal width expansion and more favorable maxillary skeletal widening with less buccal tooth displacement compared to tooth-borne RPE systems. This mechanical advantage becomes especially valuable in retreatment scenarios, where the goal is to maximize skeletal contribution while minimizing dental side effects in teeth that have already been moved once.
Criteria for selecting
re-expansion candidates
Successful MARPE re-expansion begins with rigorous case selection. The first criterion is consolidation time: the original expansion should have been retained for a minimum of 6–12 months post-appliance removal to allow bone remodeling and maturation. Patients with shorter consolidation intervals show higher risk of accelerated relapse and less stable second-stage outcomes. Second, assess the quality and stability of the original expansion using pretreatment and current CBCT imaging. If the first MARPE achieved clear midpalatal suture separation and the patient maintained gains over time, biological conditions favor re-expansion. Conversely, if the initial treatment produced only dentoalveolar widening (minimal skeletal separation), relapse is likely and indicates potential limitations in suture responsiveness. Such cases may require surgical assistance rather than a second MARPE. Third, evaluate the etiology of relapse. Is it relapse of a stable expansion (iatrogenic, due to inadequate retention or ongoing skeletal growth), or is it failure of the original treatment? These distinctions inform prognosis. Fourth, examine the patient's age and growth status. Skeletally immature patients may benefit from additional MARPE, whereas fully mature individuals with significant relapse should be evaluated for surgical alternatives or acceptance of the structural limits of the existing suture. Fifth, perform a comprehensive periodontal and endodontic assessment of anchor teeth from the prior expansion—root resorption, bone loss, or compromised tooth vitality may contraindicate a second expansion cycle.
Evaluating the healed midpalatal suture and bone
architecture
before second-stage treatment
Low-dose cone-beam computed tomography (CBCT) is mandatory before committing to MARPE re-expansion. Unlike conventional radiographs, CBCT allows three-dimensional assessment of midpalatal suture maturation, bone mineral density, and the anatomy of previously treated sites. Examine the coronal section through the palate at multiple anteroposterior levels: the anterior, middle, and posterior thirds of the suture. In a suture that has fully healed and remodeled after first-stage expansion, you will observe increased radiographic density and absence of a visible gap—this indicates maturation but does not preclude successful re-expansion if skeletal forces are reapplied. However, if CBCT shows extensive bony bridging or complete sutural obliteration, the likelihood of re-opening diminishes and surgical assistance may be necessary. Assess alveolar bone height around the anchor teeth from the original MARPE, noting any bone loss that might compromise miniscrew primary stability in the new treatment. Evaluate potential sites for new miniscrew placement: ideally, you want virgin bone with adequate thickness (≥5 mm in mesiodistal width and ≥7 mm in buccolingual depth) to accommodate 1.6 mm or 2.0 mm miniscrews at least 5 mm apart from previous screw sites. If the original MARPE used posterior miniscrews, consider anterior or lateral palatal sites for re-expansion to exploit fresh anchorage zones. A Russian patent protocol recommends baseline CBCT followed by control imaging at weeks 8 and 14 months post-expansion to verify suture maturation and bone consolidation before initiating retreatment.
Miniscrew stability in healed
bone and scar tissue
Miniscrew placement for MARPE re-expansion differs critically from primary MARPE placement because the palatal bone is no longer virgin. The previous miniscrews have left small defects or areas of altered bone architecture, and the palate itself has been widened—changing the biomechanical landscape. Primary screw stability (insertion torque) is often lower in re-expansion cases due to scarring, remodeling, and sometimes reduced bone density in areas adjacent to prior sites. To compensate, prioritize placement in areas with maximum bone volume and minimum scarring. If the original MARPE placed bilateral miniscrews at the first or second molar level, consider placing new screws 5–6 mm anterior to the original sites or in the premolar region, where bone has not been previously stressed. Alternatively, if original screws were placed at the molar level, posterior-to-anterior relocation may be limited by vascular anatomy. In such cases, lateral palatal placement or slight lateral offset from midline increases bone availability. Insertion angles and depth matter: place screws perpendicular to the palatal plane, approximately 6–8 mm in depth, to engage cortical bone and maximize contact surface. Clinical observation suggests that insertion torque of 12–20 Ncm is reasonable for re-expansion sites. Anything significantly below 10 Ncm warrants abandonment of that site and selection of an alternative. The BENEfit system and similar miniscrew platforms offer multiple head designs (plate configurations) that allow flexibility in force application vectors—choose a head design that positions the expansion screw directly along the midpalatal suture line (or as close as anatomy permits) to maximize perpendicular suture stress rather than lateral shear.
Designing activation schedules for
retreated expansion
cases
The activation protocol for MARPE re-expansion must account for the altered biology of a healed and partially scarred suture. Unlike primary expansion, where aggressive early activation (4+ turns per day) is common, re-expansion benefits from a more measured approach. Initial activation should begin conservatively—2–3 turns per day for the first 7–10 days—to establish consistent force delivery and allow initial scar tissue disruption before ramping up intensity. After this initial phase, progression to 3–4 turns per day for the remainder of the active expansion period is reasonable, targeting a total expansion duration of 6–8 weeks similar to primary MARPE but with more frequent clinical monitoring. The endpoint of active expansion is typically determined by achievement of the target skeletal widening (assessed by palatal width, inter-molar width, or incisor diastema formation) rather than by a fixed number of turns, since scar tissue resorption kinetics vary among patients. Following active expansion, a consolidation phase of 3–6 months without additional screw activation allows bone remodeling and suture healing. Some clinicians employ a “pause protocol” midway through active expansion—a 1–2 week period of no activation—to allow inflammatory response resolution and enhance suture separation. This is more relevant in re-expansion than in primary cases. Monitor for signs of inadequate suture response: if after 4–5 weeks of consistent activation the incisor diastema is <1.5 mm and maxillary width gain is minimal (<2–3 mm), consider a CBCT check to verify suture separation. If scar tissue is blocking response, further mechanical expansion may be unproductive and surgery should be discussed.
Tracking skeletal and dentoalveolar
changes during re-expansion
Clinical and radiographic monitoring during MARPE re-expansion serves two purposes: confirming that expansion is progressing and detecting early signs of miniscrew failure or inadequate suture response. At each activation visit (typically weekly during active expansion), measure and document maxillary inter-molar width using calipers, note incisor diastema width, assess palatal depth changes, and palpate the palate for suture tactile response (widening sensation). Early in active expansion (weeks 1–3), you may not detect obvious diastema formation if the initial expansion direction is primarily skeletal and suture-driven. Patience is necessary. By week 4–5, if no diastema is visible and inter-molar widening is <2 mm, this suggests either suboptimal miniscrew loading or minimal suture separation. In such cases, obtain a mid-treatment CBCT (lower radiation dose than full-spectrum imaging) to confirm suture separation status and rule out miniscrew loosening. Miniscrew stability is critical: apply lateral pressure to the expansion screw head at each visit and note any mobility. If the screw becomes loose (detectable lateral movement), discontinue loading, allow 2–3 weeks for screw stability to return, or place a new screw in an alternative site and resume loading. Expect some buccal displacement of maxillary premolars and molars during re-expansion—this is normal and reverses during the consolidation phase if adequate retention is provided post-appliance removal. At the end of active expansion (week 6–8), repeat CBCT to document final skeletal widening, suture separation, and any dentoalveolar changes. Compare baseline and final CBCT slices at identical anatomical levels (coronal sections at the anterior, middle, and posterior palate) to quantify true skeletal response. If suture separation is confirmed and target widening is achieved, proceed to consolidation. If separation is incomplete or asymmetrical, extend active expansion by 2–3 additional weeks and reimage.
Post-expansion retention strategies for
relapsed cases
Retention after MARPE re-expansion deserves special attention because relapse has already occurred once in this patient population. A longer consolidation window—6 months minimum, ideally 9–12 months—before miniscrew removal allows thorough bone maturation and reduces the risk of immediate or delayed relapse. During this consolidation phase, the expansion appliance remains passively in place (no further screw activation) to serve as a retention device. Some clinicians remove the screw mechanism after active expansion but maintain the palatal framework for mechanical resistance to closure. After miniscrew removal, employ a combination of fixed and removable retention. Fixed retention typically consists of a bonded wire or bar across the maxillary palate (palatal bar from first molar to first molar, or across the incisors) to resist transverse relapse. Removable retention includes a maxillary Hawley retainer with an anterior loop (or a full palatal acrylic pad) worn full-time for 6 months post-screw removal, then nightly for an additional 12 months. Some clinicians fabricate a maxillary clear overlay retainer (Essix or similar) in the expanded position and recommend indefinite nighttime wear for patients with a history of relapse. The decision to retain longer rests on the patient's compliance history and the magnitude of prior relapse. Assess periodontal health before and after re-expansion: if periodontal support is compromised in the original expansion teeth, relapse risk increases and retention duration should be extended. A clinical observation from orthodontic practice indicates that patients who experience relapse once have a 40–60% higher risk of recurrence without aggressive retention. Therefore, a conservative, extended retention protocol is justified in re-expansion cases.
Common challenges in MARPE retreatment and practical
solutions
MARPE re-expansion introduces specific complications that differ from primary treatment. Miniscrew failure is the most common: loosening occurs in 5–15% of re-expansion cases, particularly if initial insertion torque was suboptimal or if scar tissue prevented adequate cortical engagement. Early recognition is key—at each visit, apply gentle lateral pressure to the screw head. If mobility is detected, stop activation immediately, do not tighten further, and allow 2–3 weeks of rest. Some screws restabilize. Others require replacement. A second miniscrew placed adjacent to a failed screw can salvage the case, though each replacement reduces future placement options. Asymmetrical expansion is more common in re-expansion than in primary MARPE, especially if one screw loosens or if the healed suture has differential degrees of scarring between left and right sides. CBCT monitoring will reveal asymmetry. Respond by adjusting load distribution—increasing activation turns on the looser side or modifying the head design to vector force preferentially toward the side with greater resistance. Inadequate suture response after 4–5 weeks of consistent activation suggests either severe scarring or complete bony ankylosis of the suture. In such cases, CBCT and clinical assessment inform the decision to either extend the active phase (risking tooth damage from excessive force) or pivot to surgical assistance. Diastema persistence—visible space between incisors that does not close after miniscrew removal and retention—indicates successful skeletal expansion but may require conventional orthodontics to consolidate and close incisors in the new width. Periodontal complications (plunging gingival margin, pocketing, or bone loss) can occur in anchor teeth from the original MARPE. Monitor carefully and consider protective measures such as modified miniscrew placement away from previously loaded teeth. Root resorption in maxillary incisors is rare but possible if re-expansion coincides with aggressive orthodontic alignment forces. Use staged mechanics to separate skeletal expansion from incisor alignment. Dr. Mark Radzhabov recommends stopping expansion and reassessing if any single complication cannot be resolved within 2–3 weeks, rather than persisting with a protocol that compromises periodontal or dental health.
Published outcomes and stability data for second-stage
palatal expansion
The literature on MARPE re-expansion is sparse compared to primary expansion studies, reflecting the relative rarity of second-stage treatment. However, evidence from skeletal expansion more broadly provides useful context. A prospective randomized trial comparing MARPE to conventional RPE demonstrated that MARPE achieves significantly greater skeletal widening (increased nasal width in molar regions and greater palatine foramen expansion) with less dentoalveolar compensation—a biomechanical advantage that translates into more stable long-term outcomes and reduced anchor-tooth side effects. This superiority suggests that MARPE re-expansion, when properly executed, should yield more durable results than a second RPE cycle. Consolidation periods of 6+ months allow adequate bone maturation. Studies of surgical expansion (SARME) in adults indicate that bone density and suture fusion require extended retention—typically 3–6 months minimum—to stabilize gains. Clinical observations from orthodontic practice indicate that relapse rates for second-stage MARPE are comparable to primary MARPE when retention protocols are aggressive (9–12 months consolidation plus extended retainer wear), suggesting that with adequate support, relapse recurrence can be minimized. However, patients with a documented history of relapse carry higher inherent risk. Compliance with long-term retention is essential and should be emphasized at treatment outset. Published case reports of surgical expansion (SARME) with and without midpalatal split show that surgical approaches achieve excellent long-term stability when post-operative expansion is retained properly—suggesting that if MARPE re-expansion fails, surgical options remain available and predictable. Future research comparing second-stage MARPE to SARPE would clarify the role of miniscrew-assisted re-expansion versus surgical approaches in relapsed cases.
Learn the full MARPE protocol from Dr. Mark Rajabov
Fundamental course covering CBCT patient selection, miniscrew planning, activation protocols, and 60+ clinical cases. Choose the access level that fits your practice.
Essentials of rapid palatal expansion for practicing orthodontists.
- Core RPE concepts and biomechanics
- 6 structured video lessons
- Clinical decision checklists
- Lifetime access to recordings
Deep-dive into MARPE protocol, diagnostics, and clinical execution.
- 6 modules covering MARPE from A to Z
- CBCT case selection walkthroughs
- Miniscrew placement and activation
- 60+ annotated clinical cases
- Direct Q&A with Dr. Mark Rajabov
5-element medical consultation framework for dentists and orthodontists.
- Trust-building consultation protocol
- 5 lesson modules
- Templates for treatment plan delivery
- Works with any clinical specialty
Clinical FAQ
How long must a patient wait after initial MARPE before considering re-expansion?
Minimum 6–12 months post-appliance removal allows bone remodeling and suture maturation. Longer consolidation intervals (12+ months) correlate with improved stability and lower relapse risk during second-stage treatment.
What does CBCT reveal about the healed midpalatal suture that influences re-expansion strategy?
CBCT shows suture density, degree of bony bridging, and remaining gap anatomy. Increased density indicates maturation but does not preclude re-expansion. Complete bony obliteration may limit suture reopening and necessitate surgical assistance.
Can miniscrews be placed in the exact same location during MARPE re-expansion?
No. Placement 5–6 mm anterior to original sites or in virgin bone zones (lateral palate, premolar regions) avoids scar tissue and maximizes insertion torque. Prior screw sites show reduced bone density and compromised stability.
What activation schedule is recommended for re-expansion versus primary MARPE?
Begin re-expansion conservatively with 2–3 turns/day for 7–10 days, then progress to 3–4 turns/day. Active phase lasts 6–8 weeks. Primary MARPE typically tolerates more aggressive early loading. Re-expansion respects scar tissue resorption kinetics.
How should miniscrew stability be assessed during MARPE re-expansion treatment?
Apply gentle lateral pressure to the screw head at each visit. Any detectable mobility warrants immediate cessation of activation and 2–3 weeks rest. Persistent loosening requires screw replacement in an alternative site.
What indicators suggest that MARPE re-expansion is failing and surgical alternatives should be considered?
After 4–5 weeks of consistent activation, minimal diastema (<1.5 mm) and maxillary width gain (<2–3 mm) despite CBCT-confirmed suture separation indicate inadequate biomechanical response. Surgical expansion may be necessary.
What retention protocol is optimal for patients with prior expansion relapse history?
Extend consolidation to 9–12 months, employ combined fixed (palatal bar) and removable retention (Hawley or clear overlay), wear removable retainers full-time for 6 months post-screw removal, then nightly indefinitely.
How does MARPE re-expansion compare biomechanically to a second RPE (rapid palatal expander) cycle in relapsed cases?
MARPE provides greater skeletal response and less dentoalveolar compensation than tooth-borne RPE. This advantage translates to more durable gains and reduced anchor-tooth side effects in re-expansion scenarios.
Can MARPE re-expansion cause root resorption or periodontal damage to the original expansion teeth?
Risk is low if miniscrews are placed away from prior anchor teeth and if expansion is not combined with aggressive alignment forces. Comprehensive periodontal assessment before re-expansion is essential to identify compromised teeth that should not be re-loaded.
What is the role of CBCT imaging during the active expansion phase of MARPE retreatment?
Mid-treatment CBCT (week 4–5) confirms suture separation and excludes miniscrew loosening if clinical expansion plateaus. End-of-treatment CBCT quantifies skeletal widening and guides consolidation phase duration and retention strategy.
Successful MARPE re-expansion hinges on disciplined case selection, meticulous miniscrew placement in virgin bone, and a realistic timeline that honors the healing potential of a previously stressed suture. The evidence supports second-stage expansion in patients with adequate consolidation time, stable original expansion results, and clear motivation for further widening. If you are managing a relapsed expansion case or planning a revision MARPE treatment, Dr. Mark Radzhabov recommends a formal case review through our consultation service to assess suture maturity, bone quality, and miniscrew site anatomy before committing to treatment—ensuring the highest probability of stable, lasting skeletal expansion.
